Chong Kun Dang Pharmaceutical Corp. (KRX:185750)
South Korea flag South Korea · Delayed Price · Currency is KRW
91,000
-700 (-0.76%)
Mar 27, 2026, 3:19 PM KST

KRX:185750 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
216,236228,470219,646117,417131,813
Short-Term Investments
108,44672,549143,0958,871-
Trading Asset Securities
21,8211,1522,32429,57355,520
Cash & Short-Term Investments
346,503302,171365,065155,861187,333
Cash Growth
14.67%-17.23%134.22%-16.80%15.74%
Accounts Receivable
265,843266,742269,632248,409203,598
Other Receivables
35,38931,71140,50831,33924,697
Receivables
301,232298,453310,140279,749228,295
Inventory
428,649353,835261,432270,081224,723
Prepaid Expenses
4,0322,7612,1412,0122,127
Other Current Assets
11,4034,9337,7935,91224,670
Total Current Assets
1,091,819962,152946,572713,615667,147
Property, Plant & Equipment
437,694320,780319,787310,697298,910
Long-Term Investments
101,32342,03541,14444,01033,373
Other Intangible Assets
90,03074,51252,06226,95320,806
Long-Term Deferred Tax Assets
34,49029,66814,2136,2092,350
Long-Term Deferred Charges
17,4771,131464.72--
Other Long-Term Assets
27,46628,48628,18623,39924,114
Total Assets
1,800,2981,458,7651,402,4281,124,8831,046,700
Accounts Payable
212,899200,148183,939145,436129,327
Accrued Expenses
12,08212,72416,32311,06010,243
Short-Term Debt
91,02864,61690,95996,27074,656
Current Portion of Long-Term Debt
71,8051,88090,74027,26424,681
Current Portion of Leases
3,0332,9763,068911.362,755
Current Income Taxes Payable
13,72613,64543,93820,21113,127
Current Unearned Revenue
18.6121.9620.085.465.83
Other Current Liabilities
111,53272,54982,47873,05465,435
Total Current Liabilities
516,124368,559511,466374,213320,230
Long-Term Debt
195,196115,95330,000110,510134,246
Long-Term Leases
6,6972,7274,997782.86715.88
Pension & Post-Retirement Benefits
1,0995,8571,02386.699,454
Other Long-Term Liabilities
74,82769,29139,30818,00216,244
Total Liabilities
793,943562,387586,793503,594480,890
Common Stock
34,50732,93631,42129,97028,565
Additional Paid-In Capital
268,164261,969263,484257,685264,617
Retained Earnings
739,646671,437577,002376,371302,107
Treasury Stock
-65,920-64,151-48,143-34,666-22,435
Comprehensive Income & Other
27,358-8,222-8,070-6,967-6,843
Total Common Equity
1,003,755893,969815,694622,393566,010
Minority Interest
2,6012,409-59.33-1,104-200.34
Shareholders' Equity
1,006,356896,378815,635621,289565,810
Total Liabilities & Equity
1,800,2981,458,7651,402,4281,124,8831,046,700
Total Debt
367,758188,152219,764235,738237,054
Net Cash (Debt)
-21,255114,018145,301-79,877-49,721
Net Cash Growth
--21.53%---
Net Cash Per Share
-1596.608607.8210399.38-5933.68-3628.24
Filing Date Shares Outstanding
13.1812.5712.7312.813.01
Total Common Shares Outstanding
13.1813.213.3613.4413.66
Working Capital
575,695593,594435,106339,402346,917
Book Value Per Share
76180.1367747.6161048.8946314.7941433.07
Tangible Book Value
913,724819,456763,632595,440545,204
Tangible Book Value Per Share
69347.2862100.8457152.3944309.1039910.06
Land
214,233112,346111,145116,028108,235
Buildings
209,317208,896206,005191,667183,170
Machinery
345,173331,375292,292274,583252,066
Construction In Progress
35,4017,38321,71619,94619,901
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.